CNS β3-adrenergic receptor activation regulates feeding behavior, white fat browning, and body weight
- 1 September 2017
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 313 (3) , E344-E358
Abstract
Pharmacological β3-adrenergic receptor (β3AR) activation leads to increased mitochondrial biogenesis and activity in white adipose tissue (WAT), a process commonly referred to as “browning”, and transiently increased insulin release. These effects are associated with improved metabolic function and weight loss. It is assumed that this impact of β3AR agonists is mediated solely through activation of β3ARs in adipose tissue. However, β3ARs are also found in the brain, in areas such as the brain stem and the hypothalamus, which provide multisynaptic innervation to brown and white adipose depots. Thus, contrary to the current adipocentric view, the central nervous system (CNS) may also have the ability to regulate energy balance and metabolism through actions on central β3ARs. Therefore, this study aimed to elucidate whether CNS β3ARs can regulate browning of WAT and other aspects of metabolic regulation, such as food intake control and insulin release. We found that acute central injection of β3AR agonist potently reduced food intake, body weight, and increased hypothalamic neuronal activity in rats. Acute central β3AR stimulation was also accompanied by a transient increase in circulating insulin levels. Moreover, subchronic central β3AR agonist treatment led to a browning response in both inguinal (IWAT) and gonadal WAT (GWAT), along with reduced GWAT and increased BAT mass. In high-fat, high-sugar-fed rats, subchronic central β3AR stimulation reduced body weight, chow, lard, and sucrose water intake, in addition to increasing browning of IWAT and GWAT. Collectively, our results identify the brain as a new site of action for the anorexic and browning impact of β3AR activation.Keywords
Funding Information
- Vetenskapsrådet (Swedish Research Council)
- Novo Nordisk
- VINNOVA
- Ragnar Soderbergs stiftelse (Ragnar Söderberg Foundation)
- Harald and Greta Jeansson Foundation
- Swedish Diabetes Foundation
- Åke Wiberg Foundation
- Diabetes Wellness and Research Foundation
- Magnus Bergvall Foundation
This publication has 48 references indexed in Scilit:
- Activation of Human Brown Adipose Tissue by a β3-Adrenergic Receptor AgonistCell Metabolism, 2015
- GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPKDiabetes, 2014
- Understanding the brown adipocyte as a contributor to energy homeostasisTrends in Endocrinology & Metabolism, 2013
- Hindbrain Neurons as an Essential Hub in the Neuroanatomically Distributed Control of Energy BalanceCell Metabolism, 2012
- Brown Adipose Tissue: Function and Physiological SignificancePhysiological Reviews, 2004
- Intracerebroventricular administration of the β3-adrenoceptor agonist CL 316243 causes Fos immunoreactivity in discrete regions of rat hypothalamusNeuroscience Letters, 2000
- The pyrogenic action of cytokines1992
- Picomolar concentrations of l-DOPA stereoselectively potentiate activities of presynaptic β-adrenoceptors to facilitate the release of endogenous noradrenaline from rat hypothalamic slicesNeuroscience Letters, 1991
- Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1991
- Distribution of dopamine‐, noradrenaline‐, and adrenaline‐containing cell bodies in the rat medulla oblongata: Demonstrated by the immunocytochemical localization of catecholamine biosynthetic enzymesJournal of Comparative Neurology, 1982